We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Royal Bank Of Scotland Group Plc | LSE:RBS | London | Ordinary Share | GB00B7T77214 | ORD 100P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 120.90 | 121.35 | 121.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/10/2017 13:00 | Leeds...LOL....very good! | cfc1 | |
09/10/2017 08:37 | If I am giving focus to marxism today it is only appropriate to mention that next week it will the 100th anniversary of the October Revolution in St Petersburg which marked the beginning of the civil war and in-fighting between the different factions seeking to take control. Whilst I am not sure how those in power today in Russia with their 'life savings' safely deposited in Cypriot banks, will be marking this centenary, but I am sure that Corbyn and McDonnell will be overcome with nostalgia. | leedskier | |
09/10/2017 07:42 | Of course when Comrade Corbyn is swept to power by the snowflakes, such meetings will be totally irrelevant as the UK descends into a banana republic and a command economy . Those companies which have not fled abroad, will have been nationalised. | leedskier | |
09/10/2017 06:16 | European opening calls update courtesy of CMC MARKETS - FTSE 100 -3 at 7519, DAX +24 at 12,979, CAC 40 +15 at 5374 at 5.52am | leedskier | |
08/10/2017 12:50 | [...] Merrill Lynch Ups Motif Bio Stake Following Iclaprim Results (ALLISS) By Alliance | Fri, 6th October 2017 - 14:19 LONDON (Alliance News) - Merrill Lynch International has raised its stake Motif Bio PLC under a transaction on Wednesday and now holds 5.038% interest in the pharmaceutical company. The purchase came on the same day Motif Bio reported positive results from its phase III clinical study of flagship antibiotic Iclaprim. Iclaprim met its primary endpoint in the phase III trial in patients with acute bacterial skin and skin structure infections, which was non-inferiority whilst compared to the standard of care vancomycin. Earlier today, Motif Bio released new pre-clinical data showing positive results regarding the use of Iclaprim. In an in vivo model mimicking the pathophysiology observed in cystic fibrosis patients, rats were dosed with either 80 or 60 milligrams of Iclaprim, 50 mg of Vancomycin, and a placebo. The Iclaprim rats showed a 100% survival rate, 33 out of 33, while Vancomycin showed 92% survival rate and the placebo 48%. Merrill Lynch had a holding that was below the notable threshold prior to the purchase. Motif Bio shares were up 6% on Friday at 46.11 pence. By Joshua Warner; joshuawarner@allianc Read more: A step ahead of ImmuPharma is Motif Bio, which has successfully completed not one, but two phase III clinical trials and is preparing to submit its antibiotic, iclaprim, for regulatory sign-off. While the shares are up 23 per cent this week at around 43p, analysts think it could be worth double that figure. Amphion Innovations, the investment group, owns just over 14 per cent of Motif. Its chief executive thinks market hasn’t quite grasped how valuable this shareholding is. He might be right as Amphion’s market capitalisation is some way short of the value of its Motif investment | cool druid | |
07/10/2017 12:25 | In a week when ex Tesco directors are being tried for lying and as a result of their lying I'm on the verge of receiving compensation I have been coming to terms with the RBS Saga (where, as yet, the ex RBS directors have not been tried). The "RBoS Shareholders Action Group" have just taken on their fourth set of solicitors having falling out with the third. The third set of solicitors have contacted me with information that the Action Group have kept from the PIs - and it is alarming. As the information is "PRIVILEGED AND CONFIDENTIAL" I can't say anymore ! Will the PIs have to pay for the Action Group's spat with Signature Litigation LLP ? I don't think so ! I'll look on while they fight over the £100 million and wait for the day when this sorry Saga is finally over ! | chinese investor | |
06/10/2017 19:15 | Sometimes, a simple cartoon can say more than words.. | maxk | |
06/10/2017 07:22 | Catalan is one of the richer Spanish regions but not the richest. Its divergence from the average is shrinking. Meanwhile, German factory orders power ahead. Let’s not let facts get in the way of prejudice mind. | blusteradjuster | |
06/10/2017 06:16 | chiefbrody, I think it is the impact on 'invisible earnings' which is causing the concern. | leedskier | |
06/10/2017 06:14 | David Buik @truemagic68  European bourses take their positive lead for the opening from US & Asian markets - FTSE +14, DAX +25, CAC +11 courtesy of IG at 5.55am | leedskier | |
05/10/2017 21:22 | ^^^^You'd think it was the other way around given the scare stories the remoaners/EU keep pumping out. | chiefbrody | |
05/10/2017 20:09 | More bad brexit news.. | maxk | |
05/10/2017 16:24 | FED just stated the same as the ECB. Round of applause to the bankers that caused this over the last 20 years | dope007 | |
05/10/2017 15:48 | He is probably orchestrating it ; | leedskier | |
05/10/2017 14:46 | Isn't the standard edited by George Osborne. No axe to grind then. | manonph | |
05/10/2017 14:38 | Five former Cabinet ministers join plot to force Theresa May to quit EXCLUSIVE: 30-strong Tory group plans to oust PM before Christmas ] And the challenge is coming not from the right, but the centre left of the party. | leedskier | |
05/10/2017 14:36 | I suspect that an imminent Tory leadership challenge may be spooking the £. | leedskier | |
05/10/2017 12:40 | ECB just admitted again the EU is utterly bankrupt. Only option to continue printing trillions and hyper inflation. The £ should be far, far higher v the euro than it is | dope007 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions